BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34633684)

  • 1. Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis.
    Lu L; Yu Y; Zhang J; Fan X; Qi Y; Lin B
    J Dermatol; 2022 Jan; 49(1):e13-e15. PubMed ID: 34633684
    [No Abstract]   [Full Text] [Related]  

  • 2. Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid.
    Xiao Y; Gu Y; Xia D; Zhou X; Li W
    J Dermatol; 2023 Feb; 50(2):e76-e78. PubMed ID: 36028948
    [No Abstract]   [Full Text] [Related]  

  • 3. A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis.
    Wang G; Hu X; Han S; Zhou M
    J Dermatolog Treat; 2024 Dec; 35(1):2366535. PubMed ID: 38945532
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report.
    Yun JS; Scardamaglia L; Tan CG; McCormack CJ
    Australas J Dermatol; 2022 May; 63(2):e155-e158. PubMed ID: 35138643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with guselkumab of anti-p200 pemphigoid associated with plaque psoriasis.
    Kitayama S; Makino T; Kataoka K; Mori S; Takemoto K; Furukawa F; Torai R; Hayashi M; Mizawa M; Ishii N; Hashimoto T; Shimizu T
    J Dtsch Dermatol Ges; 2024 May; 22(5):713-715. PubMed ID: 38593343
    [No Abstract]   [Full Text] [Related]  

  • 6. Dupilumab successfully treated refractory bullous pemphigoid with early clinical manifestations imitating atopic dermatitis: A case letter.
    Zhang Y; Zhang J; Chen J; Lin M; Gong T; Cheng B; Ji C
    Australas J Dermatol; 2021 Nov; 62(4):525-527. PubMed ID: 34448201
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of bullous pemphigoid developing after ixekizumab therapy for pityriasis rubra pilaris.
    Sugihara N; Kamiya K; Nakano N; Suzuki M; Maekawa T; Murata S; Komine M; Ohtsuki M
    J Dermatol; 2023 Jun; 50(6):e185-e186. PubMed ID: 36651010
    [No Abstract]   [Full Text] [Related]  

  • 8. Bullous pemphigoid associated with psoriasis: a good response to methotrexate.
    Vargas P; Giacaman P; Fernández J; Morales C
    An Bras Dermatol; 2019; 94(2):224-226. PubMed ID: 31090831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid.
    Wang Q; Ruan Y; Guo F; Zhu H; Pan M
    Acta Derm Venereol; 2023 Sep; 103():adv12324. PubMed ID: 37707294
    [No Abstract]   [Full Text] [Related]  

  • 10. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
    Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
    Front Immunol; 2020; 11():611549. PubMed ID: 33584689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A severe case of IgA bullous pemphigoid successfully treated with dupilumab.
    Valenti M; De Giacomo P; Lavecchia A; Valenti G
    Dermatol Ther; 2022 Nov; 35(11):e15890. PubMed ID: 36181411
    [No Abstract]   [Full Text] [Related]  

  • 12. Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab.
    Fukada N; Suzuki T; Aoyama K; Kinjo A; Yamazaki K; Sato T
    J Dermatol; 2023 Feb; 50(2):e72-e73. PubMed ID: 35904019
    [No Abstract]   [Full Text] [Related]  

  • 13. Two cases with bullous pemphigoid relapsed after using interleukin-17A inhibitors for psoriasis: A paradoxical reaction.
    Wang R; Wang A; Wang M
    J Dermatol; 2023 Jul; 50(7):956-959. PubMed ID: 36880309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate.
    Gunay U; Gunduz K; Ermertcan AT; Kandiloğlu AR
    Cutan Ocul Toxicol; 2013 Jun; 32(2):168-9. PubMed ID: 22429144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efalizumab-induced bullous pemphigoid.
    Duong TA; Buffard V; André C; Ortonne N; Revuz J; Bagot M; Roujeau JC
    J Am Acad Dermatol; 2010 Jan; 62(1):161-162. PubMed ID: 20082902
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of refractory atypical bullous pemphigoid with generalized eczema and intense pruritus with dupilumab.
    Li W; Cai S; Man X
    Dermatol Ther; 2022 Feb; 35(2):e15243. PubMed ID: 34854196
    [No Abstract]   [Full Text] [Related]  

  • 17. A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis.
    Majima Y; Yagi H; Tateishi C; Groth S; Schmidt E; Zillikens D; Koga H; Hashimoto T; Tokura Y
    Br J Dermatol; 2013 Jun; 168(6):1367-9. PubMed ID: 23252972
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe pemphigoid nodularis successfully treated with dupilumab.
    Jendoubi F; Bost C; Tournier E; Paul C; Konstantinou MP
    Dermatol Ther; 2022 Sep; 35(9):e15727. PubMed ID: 35861645
    [No Abstract]   [Full Text] [Related]  

  • 19. A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis.
    Loget J; Plée J; Antonicelli F; Bernard P
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e228-e230. PubMed ID: 27730667
    [No Abstract]   [Full Text] [Related]  

  • 20. A successful case of vesicular pemphigoid concurrent with pulmonary tuberculosis with dupilumab.
    Shan Y; Zuo YG
    Dermatol Ther; 2022 Apr; 35(4):e15330. PubMed ID: 35080079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.